Understanding the infection severity and epidemiological characteristics of mpox in the UK

Abstract In May 2022, individuals infected with the monkeypox virus were detected in the UK without clear travel links to endemic areas. Understanding the clinical characteristics and infection severity of mpox is necessary for effective public health policy. The study period of this paper, from the...

Full description

Bibliographic Details
Main Authors: Thomas Ward, Christopher E. Overton, Robert S. Paton, Rachel Christie, Fergus Cumming, Martyn Fyles
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-45110-8
_version_ 1797259138510618624
author Thomas Ward
Christopher E. Overton
Robert S. Paton
Rachel Christie
Fergus Cumming
Martyn Fyles
author_facet Thomas Ward
Christopher E. Overton
Robert S. Paton
Rachel Christie
Fergus Cumming
Martyn Fyles
author_sort Thomas Ward
collection DOAJ
description Abstract In May 2022, individuals infected with the monkeypox virus were detected in the UK without clear travel links to endemic areas. Understanding the clinical characteristics and infection severity of mpox is necessary for effective public health policy. The study period of this paper, from the 1st June 2022 to 30th September 2022, included 3,375 individuals that tested positive for the monkeypox virus. The posterior mean times from infection to hospital admission and length of hospital stay were 14.89 days (95% Credible Intervals (CrI): 13.60, 16.32) and 7.07 days (95% CrI: 6.07, 8.23), respectively. We estimated the modelled Infection Hospitalisation Risk to be 4.13% (95% CrI: 3.04, 5.02), compared to the overall sample Case Hospitalisation Risk (CHR) of 5.10% (95% CrI: 4.38, 5.86). The overall sample CHR was estimated to be 17.86% (95% CrI: 6.06, 33.11) for females and 4.99% (95% CrI: 4.27, 5.75) for males. A notable difference was observed between the CHRs that were estimated for each sex, which may be indicative of increased infection severity in females or a considerably lower infection ascertainment rate. It was estimated that 74.65% (95% CrI: 55.78, 86.85) of infections with the monkeypox virus in the UK were captured over the outbreak.
first_indexed 2024-04-24T23:04:40Z
format Article
id doaj.art-3b1c7049921c4113a259617b27ceaabf
institution Directory Open Access Journal
issn 2041-1723
language English
last_indexed 2024-04-24T23:04:40Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj.art-3b1c7049921c4113a259617b27ceaabf2024-03-17T12:30:37ZengNature PortfolioNature Communications2041-17232024-03-0115111210.1038/s41467-024-45110-8Understanding the infection severity and epidemiological characteristics of mpox in the UKThomas Ward0Christopher E. Overton1Robert S. Paton2Rachel Christie3Fergus Cumming4Martyn Fyles5UK Health Security Agency, Data Analytics & SurveillanceUK Health Security Agency, Data Analytics & SurveillanceUK Health Security Agency, Data Analytics & SurveillanceUK Health Security Agency, Data Analytics & SurveillanceUK Health Security Agency, Data Analytics & SurveillanceUK Health Security Agency, Data Analytics & SurveillanceAbstract In May 2022, individuals infected with the monkeypox virus were detected in the UK without clear travel links to endemic areas. Understanding the clinical characteristics and infection severity of mpox is necessary for effective public health policy. The study period of this paper, from the 1st June 2022 to 30th September 2022, included 3,375 individuals that tested positive for the monkeypox virus. The posterior mean times from infection to hospital admission and length of hospital stay were 14.89 days (95% Credible Intervals (CrI): 13.60, 16.32) and 7.07 days (95% CrI: 6.07, 8.23), respectively. We estimated the modelled Infection Hospitalisation Risk to be 4.13% (95% CrI: 3.04, 5.02), compared to the overall sample Case Hospitalisation Risk (CHR) of 5.10% (95% CrI: 4.38, 5.86). The overall sample CHR was estimated to be 17.86% (95% CrI: 6.06, 33.11) for females and 4.99% (95% CrI: 4.27, 5.75) for males. A notable difference was observed between the CHRs that were estimated for each sex, which may be indicative of increased infection severity in females or a considerably lower infection ascertainment rate. It was estimated that 74.65% (95% CrI: 55.78, 86.85) of infections with the monkeypox virus in the UK were captured over the outbreak.https://doi.org/10.1038/s41467-024-45110-8
spellingShingle Thomas Ward
Christopher E. Overton
Robert S. Paton
Rachel Christie
Fergus Cumming
Martyn Fyles
Understanding the infection severity and epidemiological characteristics of mpox in the UK
Nature Communications
title Understanding the infection severity and epidemiological characteristics of mpox in the UK
title_full Understanding the infection severity and epidemiological characteristics of mpox in the UK
title_fullStr Understanding the infection severity and epidemiological characteristics of mpox in the UK
title_full_unstemmed Understanding the infection severity and epidemiological characteristics of mpox in the UK
title_short Understanding the infection severity and epidemiological characteristics of mpox in the UK
title_sort understanding the infection severity and epidemiological characteristics of mpox in the uk
url https://doi.org/10.1038/s41467-024-45110-8
work_keys_str_mv AT thomasward understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk
AT christophereoverton understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk
AT robertspaton understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk
AT rachelchristie understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk
AT ferguscumming understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk
AT martynfyles understandingtheinfectionseverityandepidemiologicalcharacteristicsofmpoxintheuk